It the new Nasdaq bull market gains momentum, these stocks will likely soar even higher than they already have.
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its operating and financial results for the second quarter ended June 30, 2022. “We were very pleased to have completed the sale of our complement portfolio during the second quarter to Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) (“Vertex”) for $60.0 million in cash with up to $5.0 million of that amount due in May 2023. This transaction was the
All eyes were on the Bureau of Labor Statistics (BLS) last week. On Aug. 10, BLS announced that the July Consumer Price Index for All Urban Consumers (CPI-U), arguably the most important measure of inflation, remained unchanged from the previous month at 8.5%. One day later, the agency reported that the Producer Price Index (PPI) fell by 0.5% in July.